| Index | — | P/E | 55.38 | EPS (ttm) | 0.26 | Insider Own | — | Shs Outstand | 56.46M | Perf Week | 1.05% |
| Market Cap | 813.06M | Forward P/E | 33.88 | EPS next Y | 0.43 | Insider Trans | -1.54% | Shs Float | 33.87M | Perf Month | 1.19% |
| Enterprise Value | 791.06M | PEG | 2.57 | EPS next Q | 0.09 | Short Float | 7.41% | Perf Quarter | 55.17% | ||
| Income | 15.00M | P/S | 8.05 | EPS this Y | 170.59% | Short Ratio | 3.21 | Perf Half Y | 110.22% | ||
| Sales | 101.00M | P/B | 13.55 | EPS next Y | 23.19% | ROA | 4.98% | Short Interest | 2.51M | Perf YTD | 179.61% |
| Book/sh | 1.06 | P/C | 30.11 | EPS next 5Y | 21.58% | ROE | 30.13% | 52W High | 16.15 -10.84% | Perf Year | 176.92% |
| Cash/sh | 0.48 | P/FCF | 12.14 | EPS past 3/5Y | 88.53% — | ROIC | 19.33% | 52W Low | 3.08 367.53% | Perf 3Y | 737.21% |
| Dividend Est. | — | EV/EBITDA | 27.28 | Sales past 3/5Y | 29.22% 27.86% | Gross Margin | 56.18% | Volatility | 6.03% 5.40% | Perf 5Y | 460.31% |
| Dividend TTM | — | EV/Sales | 7.83 | EPS Y/Y TTM | 107.56% | Oper. Margin | 17.01% | ATR (14) | 0.80 | Perf 10Y | 7900.00% |
| Dividend Ex-Date | — | Quick Ratio | 1.14 | Sales Y/Y TTM | 46.38% | Profit Margin | 15.67% | RSI (14) | 50.52 | Recom | 2.63 |
| Dividend Gr. 3/5Y | — | Current Ratio | 1.14 | EPS Q/Q | — | SMA20 | -3.22% | Beta | 0.87 | Target Price | 15.00 |
| Payout | 0.00% | Debt/Eq | 0.08 | Sales Q/Q | 47.37% | SMA50 | 4.56% | Rel Volume | 1.81 | Prev Close | 13.93 |
| Employees | 226 | LT Debt/Eq | 0.08 | Earnings | Nov 09 | SMA200 | 71.84% | Avg Volume | 849.17K | Price | 14.40 |
| IPO Date | Oct 10, 2007 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 83.33% 7.18% | Net Debt/EBITDA | -0.76 | Volume | 1,540,221 | Change | 3.37% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Sep-30-26 | Reiterated | DA Davidson | Buy | $12 → $15 |
| Sep-15-26 | Reiterated | Lake Street | Buy | $13 → $15 |
| Aug-11-26 | Reiterated | Barrington | Outperform | $11 → $15 |
| Aug-06-26 | Reiterated | Lake Street | Buy | $11 → $13 |
| Aug-06-26 | Reiterated | DA Davidson | Buy | $9.00 → $12 |
| Aug-03-26 | Reiterated | Barrington | Outperform | $8.00 → $11 |
| Aug-07-25 | Reiterated | DA Davidson | Buy | $8.00 → $9.00 |
| Jun-13-25 | Reiterated | DA Davidson | Buy | $6.00 → $8.00 |
| May-14-25 | Reiterated | DA Davidson | Buy | $4.50 → $6.00 |
| Apr-01-24 | Reiterated | DA Davidson | Buy | $4.00 → $4.50 |
Paysign, Inc. provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. The company offers solutions for corporate rewards, prepaid gift cards, general-purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card and software solutions. It also operates a customer service center; and offers a communication suite, including mobile app, two-way SMS, text alerts, and cardholder web portal. The company markets its prepaid card solutions under the Paysign brand. It serves companies and municipalities that require payment solutions for rewards, rebates, payment assistance, and other payments to their customers, employees, agents, and others. Paysign, Inc. was founded in 2001 and is headquartered in Henderson, Nevada.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 101 | 82 | 58 | 47 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 43 | 42 | 26 | 23 | — | — | — | — | — | |
| Gross Profit | 57 | 40 | 32 | 24 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 27 | 33 | 25 | 20 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | 13 | 0 | 6 | 4 | — | — | — | — | — | |
| Operating Income | 18 | 7 | 1 | 0 | — | — | — | — | — | |
| Interest Expense | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 4 | 3 | 3 | 3 | — | — | — | — | — | |
| Net Income Before Taxes | 19 | 10 | 4 | 2 | — | — | — | — | — | |
| Income Taxes | 4 | 2 | 0 | -4 | — | — | — | — | — | |
| Consolidated Net Income | 15 | 8 | 4 | 6 | — | — | — | — | — | |
| Net Income From Continuing Operations | 15 | 8 | 4 | 6 | — | — | — | — | — | |
| Net Income | 15 | 8 | 4 | 6 | — | — | — | — | — | |
| EPS (Recurring) | 0.29 | 0.14 | 0.07 | 0.12 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.29 | 0.14 | 0.07 | 0.12 | — | — | — | — | — | |
| EPS (Diluted) | 0.26 | 0.13 | 0.07 | 0.12 | — | — | — | — | — | |
| EBITDA | 29 | 18 | 10 | 6 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 55.38 | 39.62 | 44.02 | 23.33 | — | — | — | — | — | |
| Price To Sales Ratio | 7.98 | 3.39 | 2.76 | 3.10 | — | — | — | — | — | |
| Gross Margin | 56.44 | 48.78 | 55.17 | 51.06 | — | — | — | — | — | |
| Operating Margin | 17.82 | 8.54 | 1.72 | 0.00 | — | — | — | — | — | |
| Net Margin | 14.85 | 9.76 | 6.90 | 12.77 | — | — | — | — | — | |
| Shares Outstanding | 56 | 54 | 53 | 52 | — | — | — | — | — | |
| Market Capitalization | 806 | 278 | 160 | 146 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Newcomer Mark | CEO | Oct 09 '26 | Sale | 15.34 | 50,000 | 766,895 | 9,113,002 | Oct 14 |
| Herman Joan M | EVP, Operations | Sep 16 '26 | Sale | 11.74 | 38,900 | 456,830 | 609,421 | Sep 17 |
| Herman Joan M | EVP, Operations | Sep 15 '26 | Sale | 12.38 | 21,004 | 260,069 | 648,321 | Sep 17 |
| Ngo Michael C | Chief Innovation Officer | Sep 09 '26 | Sale | 12.74 | 79,925 | 1,018,245 | 2,350,000 | Sep 10 |
| Ngo Michael C | Chief Innovation Officer | Sep 08 '26 | Sale | 12.85 | 70,075 | 900,422 | 2,429,925 | Sep 10 |
| Cunningham Bradley Kramer | Chief Technology Officer | Jun 01 '26 | Sale | 7.80 | 3,000 | 23,400 | 348,631 | Sep 04 |
| Cunningham Bradley Kramer | Chief Technology Officer | May 29 '26 | Sale | 7.30 | 10,000 | 73,020 | 351,631 | Sep 04 |
| Turner Matthew Baker | PRES., PATIENT AFFORDABILITY | Feb 03 '26 | Sale | 4.16 | 15,057 | 62,637 | 454,943 | Sep 04 |
| Baker Jeffery Bradford | Chief Financial Officer | Aug 12 '26 | Sale | 12.62 | 35,000 | 441,637 | 542,171 | Aug 14 |
| Newcomer Mark | CEO | Aug 06 '26 | Sale | 11.88 | 150,000 | 1,781,355 | 9,163,002 | Aug 07 |
| Triplett Dennis L | Director | Aug 04 '26 | Option Exercise | 0.00 | 20,000 | 0 | 290,000 | Aug 06 |
| NEWMAN JEFFREY B | Director | Aug 04 '26 | Option Exercise | 0.00 | 20,000 | 0 | 90,000 | Aug 06 |
| Mina Bruce A | Director | Aug 04 '26 | Option Exercise | 0.00 | 20,000 | 0 | 278,500 | Aug 06 |
| HENRY DANIEL R | Director | Aug 04 '26 | Option Exercise | 0.00 | 20,000 | 0 | 169,884 | Aug 06 |
| Baker Jeffery Bradford | Chief Financial Officer | Jul 31 '26 | Option Exercise | 0.00 | 64,000 | 0 | 605,677 | Aug 04 |